CSI Market
Sign In | Register

Allergan plc (AGN) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access AGN quarterly Cash Flow →
This page allows investors to follow Allergan plc's cash flow patterns across multiple reporting periods and assess consistency in cash generation.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2019)
12 Months 		(Dec 31 2018) (Dec 31 2017) (Dec 31 2016) (Dec 31 2015)
Operating Activities
Income-5,265.10
Depreciation & amortization204.50
Amortization of Other Assets5,874.10
Minority interest0.00
Goodwill, Impairment Loss3,988.80
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase-233.20
Legal settlement0.00
Gain (Loss) on Disposition of Business0.00
Share-based Compensation214.30
Expense of compensation plans0.00
Restructuring charge0.00
Amortization Inventory Step Up-
Derivative Gain Loss On Derivative Net-
Contingent Consideration Fair Value Adjustment-
Gain Loss On Sale Of Securities And Assets-
Non Cash Impact Of Debt Extinguishment0.20
Deferred Income Taxes Expense Benefit-
Non Cash Tax Effect Of Gain Loss On Sale Of Business-
Contingent Consideration Adjustments Including Accretion Benefit Expense54.10
Taxes Paid In Connection With Sale Of Business-
Stock Issued-
Deferred Consideration For Acquisition-
Amortization Of Intangible Assets Including Discontinued Operations-
Conversion Of Stock Amount Converted-
Noncash Charges For Impairments And Related Items440.20
Dividends Payable Current-
Increase Decrease In Other Assets And Liabilities Including Receivable Or Payable With Parent305.50
Income taxes1,037.00
Gain (Loss) on Disposition of Stock in Subsidiary0.00
Increase (Decrease) in Accounts Receivable-358.80
Increase (Decrease) in Accounts Payable and Accrued Liabilities1,434.40
Accrued liabilities0.00
Derivative instruments0.00
Increase (Decrease) in Prepaid Expense and Other Assets-78.10
Other Working Capital-199.10
Other Noncash Income (Expense)-5.50
Other net0.00
Payments for (Proceeds from) Other Operating Activities-174.60
Discontinued operations0.00
Net Cash flow from Operating Activities7,238.70
Investing Activities
Capital Expenditures-433.50
Sale of Capital Items23.70
Short-term investments - liq.0.00
Short-term investments - acq.0.00
Proceeds from sales of other investments0.00
Proceeds From Sale Of Assets Including Intangibles And Businesses-
Proceeds From Sale Of Investments And Other Assets1,569.60
Purchases of other investments0.00
Minority interest 0.00
Proceeds from sale of investments0.00
Payments to Acquire Investments-3,938.00
Purchases of non-current assets0.00
Payments to Acquire Businesses, Net of Cash Acquired-80.60
Investment in affiliate0.00
Sale of businesses0.00
Proceeds from sale of assets0.00
Note receivable0.00
Other0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-2,858.80
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings11.90
Long-term debt - repayments-1,044.90
Noncontrolling interest0.00
Issuances / -repurchases of Comm. Stock-749.40
Exercise of stock options0.00
Issuances / -repurchases of Pref. Stock0.00
Discontinued Operations0.00
Other financing activities net0.00
Other net893.90
Payment Of Contingent Consideration-
Cash Held For Sale-
Movement In Cash Held For Sale-
Payment Of Contingent Consideration And Other Financing-9.30
Payments To Settlement Of Related Party Matters-
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents880.40
Dividends paid to minority interests0.00
Dividends paid-2,748.70
Net Cash Flow from Financing Activities-2,766.10
Effect of exchange rate on cash flow9.10
Discontinued operations0.00
Free Cash Flow6,828.90
Total Cash Flow1,622.90
4 historic quarters locked

Sign in to unlock the full Allergan plc cash flow history.

Sign In Create Free Account

About AGN Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

  • Form: 10-K
  • Filed with the SEC: n/a

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License